Early bone mineral density changes in treatment-naïve clinically isolated syndrome and relapsing-remitting multiple sclerosis
Background Low bone mineral density (BMD), osteopenia, osteoporosis, and fracture risk are increasingly recognized in multiple sclerosis, but data on early bone loss remain limited. We aimed to assess low BMD prevalence in newly diagnosed, treatment-naïve clinically isolated syndrome or relapsing-remitting multiple sclerosis (CIS/RRMS) patients and explore associations with clinical features and cerebrospinal fluid (CSF) immune markers. Methods This retrospective study included 76 treatment-naïve patients with CIS/RRMS who underwent dual-energy X-ray absorptiometry and CSF analysis. Patients with comorbidities, medication use, or major exposures potentially affecting BMD were excluded. Lumbar spine, femoral neck, and total femur BMD, T-scores, and Z-scores were evaluated, with BMD adjusted for age, sex, and body mass index. Associations with clinical onset characteristics, biochemical variables, and CSF immune markers were analyzed. Results The mean age was 32.9±9.52 years, and the mean baseline Expanded Disability Status Scale score was 1.29±0.89. BMD below the expected range for age was detected in 12 patients (15.8%). Femoral neck Z-score was nominally lower in patients with optic neuritis involvement at onset, while adjusted lumbar BMD was nominally higher in patients with an IgG index <0.7(p=0.037). However, these exploratory associations did not remain significant after correction. Conclusion Bone health may be affected from the early stages of CIS/RRMS, even in treatment-naïve patients with low disability and limited confounding factors. The regional differences observed between the femoral and lumbar sites, together with the borderline nominal trends with CSF-based immunological markers, suggest that the potential relationship between early neuroinflammatory processes and bone metabolism warrants further confirmation in prospective studies.
Authors
- Soner Cander (ORCID: https://orcid.org/0000-0001-6303-7896)
- Filiz Mercan Sarıdaş (ORCID: https://orcid.org/0000-0002-3135-9388)
- Güven Özkaya (ORCID: https://orcid.org/0000-0003-0297-846X)
- Emine Rabia Koç (ORCID: https://orcid.org/0000-0002-0264-7284)
- Furkan Sarıdaş (ORCID: https://orcid.org/0000-0001-5945-2317)
- Özen Öz Gül (ORCID: https://orcid.org/0000-0002-1332-4165)
Institutions
- Bursa Uludağ Üni̇versi̇tesi̇ (TR)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2026-11-18
- DOI
- https://doi.org/10.3389/fendo.2026.1952659
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00